When was Aizant founded?

Aizant was founded in 2005 and raised its 1st funding round 2 years after it was founded.

Where is Aizant located?

Aizant is headquartered in Hyderabad, India. It is registered at Sy No.172 /173, Apparel Park Road, Dulapally Vil. Dundigal Gandimaisamma Mdl, Medchal - Ma, lkajgiri, Rangareddi, Hyderabad, Telangana, India, 500100.

Who is the current CEO of Aizant?

Varma Srinivasa Rajasekara Rudraraju of Aizant.

Which legal entities is Aizant associated with?

Aizant is associated with AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED.

How many employees does Aizant have?

As of Aug 31, 2025, Aizant has 759 employees, reflecting a 1% year-over-year growth in headcount.

Is Aizant a funded company?

Aizant is a funded company, having raised a total of $16.8M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 01, 2007.

How much is Aizant worth?

The latest valuation of Aizant is ₹***** as of Mar 26, 2017.

When was the latest funding round of Aizant?

Aizant's latest funding was a $***** Series A round on Mar 26, 2017, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. In India, the Biopharma Outsourcing sector has seen $333M in funding in 2026 to date.

What is the annual revenue of Aizant?

Annual revenue of Aizant is between ₹100 Cr and ₹500 Cr as on Mar 31, 2025

Where does Aizant rank among its competitors?

Aizant ranks 8th amongst 384 active competitors, of which 15 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Almac Group, which secured $417K in Sep, 2022.

Who are the top competitors of Aizant?

Aizant's top competitors include Concord Biotech, Biophore and Almac Group. Among them, Almac Group secured the most recent funding round in September, 2022.

Aizant - 2026 Company Profile, Team, Funding, Competitors & Financials

Aizant is a series A company based in Hyderabad (India), founded in 2005 by Varma Srinivasa Rajasekara Rudraraju, Padmaja Rudraraju and Venkata Subbaraju. It operates as a Company offering contract development services for small molecules. Aizant has raised $16.8M in funding from investors like Zephyr Peacock, Zephyr Management and Pearl Lane Coinvest, with a current valuation of ₹*****. The company has 384 active competitors, including 15 funded and 91 that have exited. Its top competitors include companies like Concord Biotech, Biophore and Almac Group.

Company Details

Website: www.aizant.com/
Social
Email ID: *****@aizant.com
Phone Number: +91 **********
Registered Address: Sy No.172 /173, Apparel Park Road, Dulapally Vil. Dundigal Gandimaisamma Mdl, Medchal - Ma, lkajgiri, Rangareddi, Hyderabad, Telangana, India, 500100

Key Metrics

Founded Year

2005

Location

Hyderabad, India

Stage

Series A

Total Funding

$16.8M in 3 rounds

Latest Funding Round

Series A, Mar 26, 2017, $*****

Post Money Valuation

₹***** as on Mar 26, 2017

Investors

Zephyr Peacock & 40 more

Ranked

8^th among 384 active competitors

Annual Revenue

₹100 - ₹500 Cr as on Mar 31, 2025

Employee Count

759 as on Aug 31, 2025

Similar Companies

Concord Biotech & 429 more

View Aizant's full profile

Aizant is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED CIN: U24239TG2005PTC048133 , India, Active	Nov 22, 2005	₹100 - ₹500 Cr (As on Mar 31, 2025)	792 (As on Apr 01, 2026)

Aizant has raised a total funding of $16.8M over 3 rounds. Its first funding round was on Dec 01, 2007. Its latest funding round was a Series A round on Mar 26, 2017 for $*****. 1 investor participated in its latest round. Aizant has 13 institutional investors and 28 angel investors.

Here is the list of recent funding rounds of Aizant:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 26, 2017	4307776	Series A	8367076	8699057	3422827	4689983
Jan 14, 2011	1642754	Series A	8483051	8283655	9844750	Tarun Shah
Dec 01, 2007	5285004	Seed	2971793	1087163	Anirudh Mundra	Mafatlal Industries & 7 more

Access funding benchmarks and valuations. Sign up today!

View details of Aizant's funding rounds and investors

The founders of Aizant are Varma Srinivasa Rajasekara Rudraraju, Padmaja Rudraraju and Venkata Subbaraju.

Here are the details of Aizant's key team members:

Varma Srinivasa Rajasekara Rudraraju: Founder & CEO of Aizant. They serve on the board of 1 company.
Contact Info: 1 email address and 1 phone number
Padmaja Rudraraju: Co-Founder of Aizant.
Venkata Subbaraju: Co-Founder of Aizant.

Aizant's Board of Directors

Aizant's board has 4 active members. Varma Srinivasa Rajasekara Rudraraju is part of team and Sanjeev Kumar Sethi, Soumya Rudraraju and Rudraraju Sneha are independent board members.

Here is the list of Aizant's board of directors:

Name	Type	Representing	Status	Duration
{rxokyi	Team	-	Current	1y 3m
Sanjeev Kumar Sethi	Independent board member	-	Current	1y 9m
kornpzp	Independent board member	-	Current	7y 2m
pvpsruu	Independent board member	-	Current	7y 5m

View details of Aizant's Founder profiles and Board Members

Aizant's employee count trend

Aizant has 759 employees as of Aug 25. The total employee count is 1.0% more than what it was in Aug 24. Here is Aizant's employee count trend over the years:

Uncover Aizant's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Aizant include Concord Biotech, Biophore and Almac Group. Here is the list of Top 10 competitors of Aizant, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Concord Biotech 1984, Ahmedabad (India), Public	CDMO focused on manufacturing API	$11.3M	Quadria Capital, Helix Investments & 18 others	69/100
2nd	Biophore 2007, Hyderabad (India), Seed	Development and manufacturing of niche pharmaceutical products for the generic industry	$2.74M	Ontario & 6 others	62/100
3rd	Almac Group 2001, Craigavon (United Kingdom), Series D	CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development	$339M	Genomic Health, Gates & 4 others	57/100
4th	Indoco Remedies 1947, Mumbai (India), Public	Provider of APIs manufacturing and formulation services	-	Baring Private Equity Partners	54/100
5th	Jagsonpal 1964, Delhi (India), Public	Traditional company manufacturing bulk drugs and finished formulations	-	Convergent, Aresko	53/100
6th	Wanbury Limited 1990, Mumbai (India), Public	Manufacturer of anti-diabetic drugs	-	-	53/100
7th	Galenicum 2003, Barcelona (Spain), Late Stage	Turnkey solutions for drug development, manufacturing and regulatory approvals	-	Peninsula Capital	52/100
8th	Aizant 2005, Hyderabad (India), Series A	Company offering contract development services for small molecules	$16.8M	InvAscent, Zephyr Management & 39 others	51/100
9th	Amino 1958, Frellstedt (Germany), Unfunded	CDMO focused on amino acids and small molecules	-	-	51/100
10th	Asymchem 1995, Morrisville (United States), Public	CDMO providing comprehensive pharmaceutical development and manufacturing solutions globally	-	Hillhouse, HSG & 5 others	50/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Aizant's competitors? Click here to see the top ones

Founders (largest shareholder) own 36.63%, Funds own 15.51%, Enterprises own 18.96% and Angels own 4.70%. The net worth of Aizant's founders is INR 125Cr as of Mar 26, 2017.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	36.63%	125Cr	8632848	8747737	3593995	1056787
Varma Srinivasa Rajasekara Rudraraju	1906394	3096673	5281158	3478723	3247289	3209573
Padmaja Rudraraju	9534062	1729494	4593102	4276774	3586074	6323120
Fund	15.51%	52.8Cr	5451209	4421842	8784618	1759207
Zephyr Management	4216139	8985243	1376380	7468819	2865313	9777628
Enterprise	18.96%	64.6Cr	9642045	3080030	3155404	2973491
Angel	4.70%	17.2Cr	7333	5859	6450	5309
Anirudh Mundra	521	705	427	717	204	446
Other People	24.19%	82.4Cr	8365430	8344748	3120201	6434451
Total	100.00%	342Cr	8256728	6949887	1928642	2719646